Clinical Trial Update: Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating hyperthermia combined with immunotherapy for abdominal and pelvic cancers and metastases; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Cancer
• Cancer
• Liver Metastases
• Pelvic Cancer
• Peritoneal Metastases

Snippet

Sponsor: Capital Medical University | Conditions: Cancer, Abdominal Cancer | Phase 1, Phase 2 | Status: COMPLETED